维普中文期刊产品整合服务
46篇 您的检索式:作者名="Dickson MA"
    题名 作者 年代 出处 被引量
1Antimitochondrial antibody-negative primary biliary cirrhosis显示文摘Lacerda MA Ludwig J Dickson ER 1995Am J Gastroenterol1995,90,1:1
2Antimitochondrial antibody-negative primary biliary cirrhosis显示文摘Lacerda MA Ludwig J Dickson ER 1995Am J Gastroenterol1995,90,2:1
3Molecular pathways: CDK4 inhibitors for cancer therapy显示文摘DICKSON MA 2014Clin Cancer Res2014,20,13:1
4QR De- composition-based Matrix inversion for high perform ance embedded MIMO receivers显示文摘MA L DICKSON K MCALLISTER J 2011IEEE Transcations on Signal Processing2011,59,4:1
5Antimitochondrial antibody-negative primary biliary cirrhosis 显示文摘LACERDA MA LUDWIG J DICKSON ER 1995Am J Gastroenterology1995,90,2:1
6Development of cell-cycle inhibitors forcancer therapy显示文摘Dickson MA Schwartz GK 2009Curr Oncol2009,16,2:1
7Socially responsible be havior: values and attitudes of the alternative trading or- ganization consumer显示文摘DICKSON MA LITTRELL MA 1996Journal of Fashion Marketing and Management: an International Journal1996,1,1:1
8A characterization of polymethyhnethacrylate bone cement 显示文摘Haas SS Brauer GM Dickson MA 1975J Bone and Joint Surg1975,57,38:1
9Human keratinoeytes that express hTERT and also bypass a p16 (INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics 显示文摘Dickson MA Hahn WC Ino Y 2000Mol Cell Biol2000,20,4:1
10Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics显示文摘 Hahn WC Ino Y 2000Mol Cell Biol2000,20,4:1
11Development of cell-cycle in- hibitors for cancer therapy显示文摘Dickson MA Schwartz GK 2009Curt Oncol2009,16,2:1
12QR decomposition- based matrix inversion for high performance embedded MIMO receivers显示文摘MA L DICKSON K MCALLISTER J 2011IEEE Transactions on Signal Processing2011,59,4:1
13Development of ceil-cycle inhibitors for cancer therapy显示文摘Dickson MA Schwartz GK 2009Curr Oncol2009,16,1:1
14Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differ-entiation characteristics 显示文摘Dickson MA Hahn WC Ino Y 2000Mol Cell Biol2000,20,4:1
15Development of cell-cycle inhibitors for cancer therapy 显示文摘Dickson MA Schwartz GK 2009Curr Oncol2009,16,2:1
16Antimitochondrial antibody-negative primary biliary cirrhosis显示文摘Lacerda MA Ludwig J Dickson ER 0,,:1
17Molecular Pathways:CDK4 inhibitors for cancer therapy显示文摘Dickson MA 2014Clin Cancer Res2014,5,:1
18Phase Ⅰ study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors显示文摘Rathkopf D Dickson MA Feldman DR 2009Clin Cancer Res2009,15,23:1
19Human Keratinocytes that express hTERT and also bypass a p16INK4a enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics显示文摘Dickson MA Hahn WC Ino Y 2000Mol Cell Biol2000,20,:1
20QR decomposition-basedmatrix inversion for high performance embedded MIMOreceivers显示文摘Ma L Dickson K and McAllister J 2011IEEE Transactions on Signal Processing2011,59,4:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费